We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Microsoft and GE Launch Healthcare Technology Company

By HospiMedica International staff writers
Posted on 08 Jun 2012
General Electric Co., through its healthcare IT business, GE Healthcare (Chalfont St. More...
Giles, UK), and Microsoft Corp. (Redmond, WA, USA) announced the completion of their joint venture, Caradigm (Bellevue, Washington, USA).

Caradigm focuses on improving healthcare quality and patient experience through the use of real-time systems, an open technology platform, and collaborative clinical applications. Plans for the joint venture were first announced on Dec. 7, 2011, and the final agreement was completed on June 1, 2012.

The Caradigm board of directors and leadership team is comprised of executives from both parent companies. Caradigm appointed Michael Simpson, a former GE Healthcare executive, as CEO, Lauren Salata, formerly of Care Innovations, an Intel and GE company, as chief financial officer, and Michael Willingham, formerly of Philips Healthcare, as quality assurance and regulatory affairs executive.

“The combination of people and technology from GE Healthcare and Microsoft will allow us to drive the dramatic change that is needed in healthcare,” said Mr. Simpson. “By forming Caradigm, we can offer innovative healthcare solutions, including an open platform and tools that enable software developers around the world to address the complexities of population health today.”

Caradigm will feature products from both GE Healthcare and Microsoft, including Microsoft’s Amalga health-care data system, a unified health enterprise platform that retrieves and displays patient information, such as data from medical imaging procedures, lab results, and surgeries.

Caradigm will be headquartered in Bellevue, Washington, USA, with significant presence in other cities around the world.

Related Links:

GE Healthcare
Microsoft Corp.
Caradigm



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.